Cloxacillin Vital Pharma Nordic Stungulyfs-/innrennslisstofn, lausn 2 g Ísland - íslenska - LYFJASTOFNUN (Icelandic Medicines Agency)

cloxacillin vital pharma nordic stungulyfs-/innrennslisstofn, lausn 2 g

vital pharma nordic aps - cloxacillinum natríum - stungulyfs-/innrennslisstofn, lausn - 2 g

Imvanex Evrópusambandið - íslenska - EMA (European Medicines Agency)

imvanex

bavarian nordic a/s - breytt bóluefni ankara - bavarian nordic (mva-bn) veira - smallpox vaccine; monkeypox virus - Önnur veiru bóluefni, - active immunisation against smallpox, monkeypox and disease caused by vaccinia virus in adults (see sections 4. 4 og 5. notkun þetta bóluefni ætti að vera í samræmi við opinbera tillögur.

Losartan Medical Valley Filmuhúðuð tafla 12,5 mg Ísland - íslenska - LYFJASTOFNUN (Icelandic Medicines Agency)

losartan medical valley filmuhúðuð tafla 12,5 mg

medical valley invest ab - losartanum kalíum - filmuhúðuð tafla - 12,5 mg

Losartan Medical Valley Filmuhúðuð tafla 100 mg Ísland - íslenska - LYFJASTOFNUN (Icelandic Medicines Agency)

losartan medical valley filmuhúðuð tafla 100 mg

medical valley invest ab - losartanum kalíum - filmuhúðuð tafla - 100 mg

Losartan Medical Valley Filmuhúðuð tafla 50 mg Ísland - íslenska - LYFJASTOFNUN (Icelandic Medicines Agency)

losartan medical valley filmuhúðuð tafla 50 mg

medical valley invest ab - losartanum kalíum - filmuhúðuð tafla - 50 mg

Teysuno Evrópusambandið - íslenska - EMA (European Medicines Agency)

teysuno

nordic group b.v. - tegafúri, gimeracil, oteracil - magaæxli - Æxlishemjandi lyf - teysuno is indicated in adults:- for the treatment of advanced gastric cancer when given in combination with cisplatin (see section 5. - as monotherapy or in combination with oxaliplatin or irinotecan, with or without bevacizumab, for the treatment of patients with metastatic colorectal cancer for whom it is not possible to continue treatment with another fluoropyrimidine due to hand-foot syndrome or cardiovascular toxicity that developed in the adjuvant or metastatic setting.

Gaviscon Mixtúra, dreifa Ísland - íslenska - LYFJASTOFNUN (Icelandic Medicines Agency)

gaviscon mixtúra, dreifa

nordic drugs ab - calcii carbonas; aluminii hydroxidum; natrii hydrogenocarbonas; natrii alginas - mixtúra, dreifa

Gaviscon Tuggutafla Ísland - íslenska - LYFJASTOFNUN (Icelandic Medicines Agency)

gaviscon tuggutafla

nordic drugs ab - aluminium hydroxide; sodium hydrogen carbonate; acidum alginicum - tuggutafla

Penovet vet. Stungulyf, dreifa 300 .000 a.e./ml Ísland - íslenska - LYFJASTOFNUN (Icelandic Medicines Agency)

penovet vet. stungulyf, dreifa 300 .000 a.e./ml

boehringer ingelheim animal health nordics a/s - benzylpenicillinprocainum - stungulyf, dreifa - 300 .000 a.e./ml

Selevitan, vet. Stungulyf, lausn Ísland - íslenska - LYFJASTOFNUN (Icelandic Medicines Agency)

selevitan, vet. stungulyf, lausn

boehringer ingelheim animal health nordics a/s - natrii selenis; tocopherolum (alfa) acetat - stungulyf, lausn